股浅动脉中长度TASC II B和C型病变的血管内治疗与股腘动脉搭桥手术：一项观察性倾向匹配分析 - Suppr | 超能文献

相似文献

1

Endovascular therapy versus femoropopliteal bypass surgery for medium-length TASC II B and C lesions of the superficial femoral artery: An observational propensity-matched analysis.股浅动脉中长度TASC II B和C型病变的血管内治疗与股腘动脉搭桥手术：一项观察性倾向匹配分析

Vascular. 2019 Oct;27(5):542-552. doi: 10.1177/1708538119837134. Epub 2019 Mar 19.

2

Outcomes of bypass and endovascular interventions for advanced femoropopliteal disease in patients with premature peripheral artery disease.伴有早发周围动脉疾病的患者中，晚期股腘动脉病变的旁路和血管内介入治疗的结果。

J Vasc Surg. 2021 Dec;74(6):1968-1977.e3. doi: 10.1016/j.jvs.2021.05.034. Epub 2021 Jun 6.

3

Endovascular treatment of TransAtlantic Inter-Society Consensus II D femoropopliteal lesions in patients with critical limb ischemia.腔内治疗 TASC II D 型股腘动脉病变在伴有严重肢体缺血的患者。

J Vasc Surg. 2019 May;69(5):1510-1518. doi: 10.1016/j.jvs.2018.08.176. Epub 2019 Jan 2.

4

A Comparative Cost-Effectiveness Analysis of Percutaneous Transluminal Angioplasty With Optional Stenting and Femoropopliteal Bypass Surgery for Medium-Length TASC II B and C Femoropopliteal Lesions.经皮腔内血管成形术伴或不伴支架置入与股腘旁路手术治疗 TASC II B 和 C 型中等长度股腘病变的成本效果比较分析

J Endovasc Ther. 2019 Apr;26(2):172-180. doi: 10.1177/1526602819833646.

5

Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.股腘动脉TASC II D型病变的血管内治疗与旁路手术比较：一项单中心研究

Ann Vasc Surg. 2018 Feb;47:179-187. doi: 10.1016/j.avsg.2017.09.008. Epub 2017 Sep 22.

6

Endovascular Therapy Provides Similar Results of Bypass Graft Surgery in the Treatment of Infrainguinal Multilevel Arterial Disease in Patients with Chronic Limb-Threatening Ischemia in All GLASS Stages.在所有GLASS分期的慢性肢体威胁性缺血患者中，血管内治疗在治疗股腘多节段动脉疾病方面提供了与旁路移植手术相似的结果。

Ann Vasc Surg. 2020 Oct;68:400-408. doi: 10.1016/j.avsg.2020.04.028. Epub 2020 Apr 25.

7

In Situ Vein Bypass Is Superior to Endovascular Treatment of Femoropopliteal Lesions in Chronic Limb-Threatening Ischemia.原位静脉旁路术在慢性肢体威胁性缺血中治疗股腘动脉病变优于血管腔内治疗。

Ann Vasc Surg. 2020 Aug;67:437-447. doi: 10.1016/j.avsg.2020.03.035. Epub 2020 Mar 29.

8

Rapid increase in hybrid surgery for the treatment of peripheral artery disease in the Vascular Quality Initiative database.血管质量倡议数据库中杂交手术治疗外周动脉疾病的快速增长。

J Vasc Surg. 2020 Sep;72(3):977-986.e1. doi: 10.1016/j.jvs.2019.11.041. Epub 2020 Feb 14.

9

Nitinol Stent Versus Bypass in Long Femoropopliteal Lesions: 2-Year Results of a Randomized Controlled Trial.镍钛诺支架与旁路治疗长段股浅动脉病变：一项随机对照试验的 2 年结果。

JACC Cardiovasc Interv. 2019 Dec 23;12(24):2541-2549. doi: 10.1016/j.jcin.2019.09.006. Epub 2019 Nov 27.

10

Long-Term Limb Salvage and Amputation-Free Survival After Femoropopliteal Bypass and Femoropopliteal PTA for Critical Ischemia in a Clinical Cohort.临床队列中股腘动脉旁路移植术和股腘动脉经皮腔内血管成形术治疗严重肢体缺血后的长期肢体挽救及无截肢生存情况

Vasc Endovascular Surg. 2019 Feb;53(2):112-117. doi: 10.1177/1538574418813741.

引用本文的文献

1

An unusual presentation of component separation after percutaneous transmural arterial bypass (PTAB).经皮腔内动脉搭桥术（PTAB）后出现的一种不寻常的组织分离表现。

J Vasc Surg Cases Innov Tech. 2025 May 8;11(4):101838. doi: 10.1016/j.jvscit.2025.101838. eCollection 2025 Aug.

2

Predictive Factors of Wound Healing and Limb Salvage After Successful Below-the-Knee Endovascular Angioplasty in Patients with Diabetic Foot Ulcer: A Retrospective Study.糖尿病足溃疡患者膝下血管腔内血管成形术成功后伤口愈合和保肢的预测因素：一项回顾性研究

Medicina (Kaunas). 2025 Feb 6;61(2):277. doi: 10.3390/medicina61020277.

3

Endovascular Transvenous versus Open Femoropopliteal Bypass.